Amphenol’s Order Book Is Screaming Growth — So Why Is the Stock Catching Its Breath?

There’s an old Wall Street adage that insider selling is a red flag. Amphenol’s recent weeks have done their best to dismantle that notion, as two of the connector maker’s top executives cashed in options at the start of August while the company’s underlying business posts numbers that most industrial firms can only dream about.

The disconnect between the share price and the operational reality is striking. The stock currently trades around €135.78, below its 50-day moving average of €140.31, even after delivering what management describes as one of the strongest quarters in company history. The market’s hesitance, however, looks less like a verdict on the business and more like a technical digestion phase following a powerful run that pushed the shares to a 52-week high.

The Numbers That Matter

Amphenol’s second-quarter results, released in late July, were nothing short of exceptional. Revenue hit a record $8.8 billion, up 55 percent year over year, with organic growth contributing 30 percentage points of that gain. Adjusted earnings per share climbed 67 percent to $1.35, beating analyst expectations by 16.4 percent and coming in 7.5 percent above forecasts.

The most telling figure, though, is the order intake: $10.7 billion, translating to a book-to-bill ratio of 1.23. The company is pulling in more orders than it can currently process — a forward-looking indicator that carries more weight than any snapshot of the share price. Adjusted operating margin also expanded by 420 basis points to a record 29.8 percent, proving that Amphenol isn’t buying growth at the expense of profitability.

A Split and Insider Sales: Noise, Not Signal

The stock’s recent softness — down about 9.8 percent from post-split levels — has two technical explanations. First, the two-for-one split completed in September was always going to create some consolidation pressure after such a strong run. Second, insider selling has weighed on sentiment.

Chief Financial Officer Craig Lampo exercised 193,200 options at $22.3725 apiece on August 4, selling them at an average of $167.31. The following day, HR chief David M. Silverman exercised 120,000 options at $21.995 and sold at a weighted average of $174.24. Lampo also transferred 54,547 shares indirectly into a trust. Combined, insider sales over the past 90 days exceed $170 million.

Should investors sell immediately? Or is it worth buying Amphenol?

But here’s the thing about options exercised at decades-old strike prices: profit-taking is almost routine. A split is a purely mechanical adjustment that doesn’t alter fundamental value, and executives realizing gains after a massive rally — the stock is up 16 percent year to date and 45 percent over twelve months — is hardly a commentary on the company’s health.

CommScope Integration Beats Expectations

What’s arguably more significant is how quickly the CommScope acquisition is outperforming initial projections. Amphenol acquired the CCS division and originally guided for $4.1 billion in annual revenue from the unit. That forecast has now been raised to $4.6 billion, while the expected EPS contribution has doubled from $0.15 to $0.30 per share.

Such upward revisions within months of closing a deal suggest either conservative initial planning or demand accelerating faster than anticipated — both of which speak to the quality of the business. The company’s third-quarter guidance calls for revenue of $9.3 billion to $9.4 billion, up 50 to 52 percent year over year, with adjusted EPS of $0.70 to $0.71 on a post-split basis.

The Market Hasn’t Caught Up Yet

One curious detail: there haven’t been fresh analyst notes in recent weeks processing the record results. The latest price-target hikes from Citi, UBS, and BofA date back to July, before the Q2 print. That means the market hasn’t fully incorporated the updated guidance into current valuations — a sign that the debate over fair value may only be getting started.

The shares closed Friday at €136.74, down 1.3 percent on the day but up 2.5 percent for the week. They sit 12 percent below the 52-week high of €156.26, yet remain a staggering 50 percent above the year’s low from September 2 — a reminder of just how far the stock has traveled. A dividend of $0.25 per share pre-split ($0.125 adjusted) is scheduled for October 14.

A Breather, Not a Warning

Amphenol sits squarely in the middle of the structural shift toward data centers, networking infrastructure, and AI-driven demand for high-performance connectivity. Record orders, expanding margins, and an acquisition that keeps looking better all point in one direction. The recent pullback reads as noise around a split and insider transactions — not as a judgment on the business model. For investors willing to look past the technicals, the consolidation looks more like a pause than a problem.